DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $809,746,656 | -2.7% | 3,263,755 | -5.9% | 0.27% | +0.4% |
| Q2 2023 | $832,335,102 | +6.5% | 3,468,146 | +11.9% | 0.26% | +0.8% |
| Q1 2023 | $781,355,909 | +97139.2% | 3,100,235 | +2.4% | 0.26% | +11.0% |
| Q4 2022 | $803,540 | -99.9% | 3,027,388 | +3.1% | 0.24% | -18.6% |
| Q3 2022 | $758,566,000 | +3.2% | 2,936,608 | +1.3% | 0.29% | +10.2% |
| Q2 2022 | $735,110,000 | -14.9% | 2,899,794 | -1.5% | 0.26% | -0.8% |
| Q1 2022 | $863,454,000 | -10.0% | 2,943,428 | +0.9% | 0.27% | -8.3% |
| Q4 2021 | $959,308,000 | +9.0% | 2,915,781 | +0.9% | 0.29% | +2.1% |
| Q3 2021 | $880,140,000 | +13.4% | 2,890,865 | -0.1% | 0.28% | +15.4% |
| Q2 2021 | $776,389,000 | +18.4% | 2,892,993 | -0.7% | 0.25% | +13.4% |
| Q1 2021 | $655,836,000 | -4.1% | 2,913,896 | -5.4% | 0.22% | -12.1% |
| Q4 2020 | $684,082,000 | -5.0% | 3,079,578 | -7.9% | 0.25% | -19.0% |
| Q3 2020 | $719,722,000 | +19.6% | 3,342,712 | -1.8% | 0.30% | +15.5% |
| Q2 2020 | $601,707,000 | +27.8% | 3,403,093 | +0.0% | 0.26% | +7.8% |
| Q1 2020 | $470,914,000 | -10.0% | 3,402,114 | -0.3% | 0.24% | +28.3% |
| Q4 2019 | $523,525,000 | -4.0% | 3,411,078 | -9.7% | 0.19% | -9.9% |
| Q3 2019 | $545,570,000 | -3.0% | 3,777,683 | -4.0% | 0.21% | -2.8% |
| Q2 2019 | $562,480,000 | +8.2% | 3,935,723 | -0.1% | 0.22% | +5.3% |
| Q1 2019 | $519,926,000 | +29.0% | 3,938,547 | +0.7% | 0.21% | +13.1% |
| Q4 2018 | $403,127,000 | -5.2% | 3,909,502 | -0.1% | 0.18% | +13.0% |
| Q3 2018 | $425,144,000 | +7.8% | 3,912,763 | -2.1% | 0.16% | +3.2% |
| Q2 2018 | $394,370,000 | -0.3% | 3,996,413 | -1.1% | 0.16% | -4.8% |
| Q1 2018 | $395,587,000 | -3.0% | 4,040,315 | -8.0% | 0.16% | -2.4% |
| Q4 2017 | $407,810,000 | +2.7% | 4,393,280 | -5.1% | 0.17% | -2.9% |
| Q3 2017 | $397,144,000 | +3.1% | 4,630,035 | +1.4% | 0.17% | -2.2% |
| Q2 2017 | $385,379,000 | -3.3% | 4,566,708 | -2.0% | 0.18% | -6.8% |
| Q1 2017 | $398,696,000 | +29.4% | 4,661,469 | +17.8% | 0.19% | +24.0% |
| Q4 2016 | $308,122,000 | +39.6% | 3,958,245 | +40.6% | 0.15% | +29.4% |
| Q3 2016 | $220,727,000 | +19.0% | 2,816,077 | +53.3% | 0.12% | +11.2% |
| Q2 2016 | $185,511,000 | +6.0% | 1,836,813 | -0.4% | 0.11% | +1.9% |
| Q1 2016 | $174,964,000 | +7.3% | 1,844,435 | +5.1% | 0.10% | +2.9% |
| Q4 2015 | $163,007,000 | +14.1% | 1,754,996 | +4.7% | 0.10% | +8.5% |
| Q3 2015 | $142,815,000 | -7.3% | 1,676,133 | -6.9% | 0.09% | 0.0% |
| Q2 2015 | $154,023,000 | +11.7% | 1,799,575 | +10.8% | 0.09% | +8.0% |
| Q1 2015 | $137,917,000 | +25.7% | 1,624,444 | +26.9% | 0.09% | +20.8% |
| Q4 2014 | $109,740,000 | +44.0% | 1,280,290 | +27.7% | 0.07% | +33.3% |
| Q3 2014 | $76,190,000 | +3.1% | 1,002,749 | +6.8% | 0.05% | +5.9% |
| Q2 2014 | $73,912,000 | +3.5% | 938,764 | -1.4% | 0.05% | -3.8% |
| Q1 2014 | $71,388,000 | -1.6% | 952,028 | +1.4% | 0.05% | -7.0% |
| Q4 2013 | $72,512,000 | +25.5% | 939,329 | +12.7% | 0.06% | +14.0% |
| Q3 2013 | $57,766,000 | +10.7% | 833,313 | +1.1% | 0.05% | +2.0% |
| Q2 2013 | $52,168,000 | – | 824,073 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |